In contrast, in two cohort studies, higher levels of Eotaxin in the plasma were not associated with Alzheimer’s disease progression (Westin et al., 2012, Leung et al., 2013). This evidence concerns the gene CCL11 and early-onset autosomal dominant Alzheimer disease.